Related references
Note: Only part of the references are listed.Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease
Xi Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
Johanne Poisson et al.
JOURNAL OF HEPATOLOGY (2017)
Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis
Longwei Liu et al.
NATURE MATERIALS (2017)
Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis
Srimathi Srinivasan et al.
ANGIOGENESIS (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Liver Sinusoidal Endothelial Cells in Hepatic Fibrosis
Laurie D. DeLeve
HEPATOLOGY (2015)
Fibrosis - A Common Pathway to Organ Injury and Failure
Maria L. Urban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
Qin Pan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Josef Ehling et al.
GUT (2014)
Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions
Yasuko Iwakiri et al.
JOURNAL OF HEPATOLOGY (2014)
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis
Tokuhiro Matsubara et al.
HEPATOLOGY (2013)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells
Qi Cheng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Guanhua Xie et al.
GASTROENTEROLOGY (2012)
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
Hacer Sahin et al.
HEPATOLOGY (2012)
Angiogenesis in chronic liver disease and its complications
Stephanie Coulon et al.
LIVER INTERNATIONAL (2011)
Now There Are Many (Stages) Where Before There Was One: In Search of a Pathophysiological Classification of Cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2010)
Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease
Olivier Rosmorduc et al.
SEMINARS IN LIVER DISEASE (2010)
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
M. Hennenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Effect of Fuzheng Huayu formula and its actions against liver fibrosis
Chenghai Liu et al.
Chinese Medicine (2009)
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
Laurie D. DeLeve et al.
HEPATOLOGY (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells
Erica Novo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B
Ping Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Cirrhosis reversal: a duel between dogma and myth
VJ Desmet et al.
JOURNAL OF HEPATOLOGY (2004)
Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis
H Yoshiji et al.
GUT (2003)
Share Paper
